Nicotine Modifies Cytokine Production by Human Mononuclears Stimulated by Colon Cancer Cells
Journal Title: Colorectal Cancer: Open Access - Year 2017, Vol 3, Issue 2
Abstract
Background: The undesirable effects of prolonged tobacco use and cigarette smoking are well-known and are due to inhalation of a great number of alkaloids including nicotine. Lung cancer is the most feared ailment in chronic smokers and its linkage with nicotine is not always justified. Notably, it has been shown that nicotine possesses anti-inflammatory properties and considering the link between chronic inflammation and cancer it is conceivable to assume that nicotine may reduce tumorigenesis. Our task was to examine the capacity of nicotine to promote peripheral blood mononuclear cells (PBMC) for cytokine production and to assess its ability to modify the cross-talk between immune and colon cancer cells. Methods: Unstimulated and LPS stimulated PBMC were incubated with various concentrations of nicotine and the generation of the cytokines TNFα, IL-1β, IL-6, IFNγ, IL-2, IL-10, and IL-1ra was detected. In addition, the production of these cytokines was examined in co-cultures of PBMC with HT-29 or RKO colon carcinoma cells in the presence of nicotine. Results: Nicotine caused inhibition of TNFα, IL-6, IL-1β and IL-1ra secretion by non-stimulated PBMC and reduced IL-6 and IFNγ production by mitogen stimulated cells. The effect of nicotine on the immune function of PBMC became prominent when the cells were triggered for cytokine production by HT-29 colon carcinoma cells. The secretion of the pro-inflammatory cytokines TNFα, IL-1β, IL-2 and IFNγ was inhibited, whereas that of IL-6 was not affected. Cytokine production by PBMC induced by RKO cells was not affected by nicotine at any of the concentrations used, suggesting cell-specific immune response. Conclusion: Nicotine inhibited the production of proinflammatory cytokines by PBMC. This effect was more conspicuous when PBMC were promoted by HT-29 colon carcinoma cells. It is feasible that nicotine, acting as an anti-inflammatory agent, may modulate the cross-talk between immune and cancer cells and to delay the progress of carcinogenesis.
Authors and Affiliations
Djaldetti M, Bessler H
Keywords
Related Articles
- EP ID EP331769
- DOI 10.21767/2471-9943.100046
- Views 100
- Downloads 0
Second Gastric Cancer After the Treatment of Primary Stomach Diffuse Large B-Cell Lymphoma
We report a case of gastric carcinoma occurred 11 years after treatment of gastric lymphoma in a 38-year-old patient with a review of the literature.
Colic Adenocarcinoma Revealed by Ileo-Colic Intussusception
Introduction: Intussusception is unusual in adults; it accounts for 5% of intestinal occlusions at this age. It is most often secondary to a benign or malignant organic lesion. Result: Through this observation, we repor...
Effects of Adjuvant Oxaliplatin on Anal Function in Locally Advanced Rectal Cancer Treated with Preoperative Chemo-Radiotherapy and Low Anterior Resection
Background: The main objective of this study was to find out if the application of adjuvant oxaliplatin (OXA) influences sphincter function in patients with locally advanced rectal cancer (LARC) treated with preoperative...
Updates on the Molecular Genetics of Colorectal Cancer
Colorectal cancer (CRC) is a leading cause of cancer mortality worldwide. Although definitive therapies for advanced disease are still lacking, rapid progress has been made in the last decade in understanding the molecul...
Impact of a Goal Directed Fluid Therapy on Length of Hospital Stay and Costs of Hepatobiliary Pancreatic Surgery. A Prospective Observational Study
The article entitled "Impact of a Goal Directed Fluid Therapy on Length of Hospital Stay and Costsof Hepatobiliary Pancreatic Surgery. A Prospective Observational Study" has been accepted for publication in the Colorecta...